Implementation of Intensive Hypertension Management Approaches: Cleveland Clinic
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- Anita Misra-Hebert
- Study ID
- NCT07232017
- Status
- Recruiting
Conditions
- Hypertension (HTN)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- IN-HOME BP — OTHERA team-based approach with a primary care provider (PCP) collaborating with pharmacists and advanced practice providers (APP) and will use a mechanism (frequent follow-up- phone or virtual appointments) that allows titrating blood pressure medications based on patient-recorded home blood pressure readings.
Study Details
The primary objective of the Implementation of Effective Hypertension Management Approaches: Cleveland Clinic program is to improve blood pressure control for patients diagnosed with hypertension (HTN) and uncontrolled blood pressure, specifically defined as a blood pressure greater than 150/95, across all Cleveland Clinic Northeast Ohio primary care practices. The project will scale up the availability of resources for treating hypertension in 56 primary care practices within the Cleveland Clinic Health System in Northern Ohio, reaching up to approximately 3800 patients. This project will utilize evidence from a randomized controlled trial by Margolis et al.(1) to build upon Cleveland Clinic's existing team-based primary care provider (PCP) collaboration with pharmacists and advanced practice providers (APP) and will use a mechanism that allows titrating blood pressure medications based on patient-recorded home blood pressure readings.
Key Dates
- Start date
- Jan 6, 2026
- Status verified
- Jan 2026
- Primary completion
- Apr 30, 2029
- Completion
- Jul 31, 2029
Study Design
- Enrollment
- 1,520 participants (estimated)
Arms
- Arm: IN-HOME BP: titrating BP medications based on patient-recorded home blood pressure readingsThis project will utilize evidence from a randomized controlled trial by Margolis et al.(1) to build upon Cleveland Clinic's existing team-based primary care provider (PCP) collaboration with pharmacists and advanced practice providers (APP) and will use a mechanism that allows titrating blood pressure medications based on patient-recorded home blood pressure readings.
Primary Outcome Measure
Systolic Blood Pressure Change [ Time Frame: Patients will be followed for up to 33 months: 24-month implementation/intervention period and 9-month maintenance period. ]
Central Contacts
- Anita Misra-Hebert, MD, MPH, FACP216-445-8542
- Christopher Babuich, MD440 204-7400
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cleveland Clinic | Cleveland | Ohio | 44195 | - |
Find similar trials in Cleveland, OH
Related Studies
- Clinical Decision Support Tool for the Treatment of Uncontrolled HypertensionNot Yet Recruiting · The Cleveland Clinic · Cleveland, Ohio
- Actions to Decrease Disparities in Risk and Engage in Shared Support for Blood Pressure Control (ADDRESS-BP) in BlacksEnrolling By Invitation · NYU Langone Health · New York, New York
- Genetic Architecture of Natriuretic Peptides and Blood Pressure ResponseNot Yet Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney DiseasePHASE3 · Recruiting · Sarfez Pharmaceuticals, Inc. · Vienna, Virginia